BioScience Health Innovations (BHIC) Notes Payables (2021 - 2026)
BioScience Health Innovations (BHIC) posted quarterly Notes Payables of $460402.0 for Q1 2026, up 6430.52% quarter-over-quarter from $7050.0 in Q2 2022.
BioScience Health Innovations (BHIC) Notes Payables (2021 - 2026) Analysis & Trends
BioScience Health Innovations (BHIC) has reported Notes Payables for 3 consecutive years, with $460402.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Notes Payables changed N/A year-over-year to $460402.0; the TTM figure through Mar 2026 stood at $460402.0 (changed N/A YoY), while the FY2021 annual figure was $7050.0, changed N/A from the prior year.
- Notes Payables improved to $460402.0 in Q1 2026 per BHIC's latest filing, from $7050.0 in the prior quarter.
- Across five years, Notes Payables topped out at $460402.0 in Q1 2026 and bottomed at $7050.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | High Tide | 215.72 Mn | 182.44 Mn | 35.30 Mn |
| 2 | BioScience Health Innovations | 46.85 Mn | 46.14 Mn | 659,483.00 |
| 3 | Petmed Express | 38.27 Mn | 25.17 Mn | 11.33 Mn |
| 4 | Scienture Holdings | 18.71 Mn | 18.71 Mn | 335,779.00 |
| 5 | Polomar Health Services | 8.48 Mn | 8.31 Mn | 935,916.00 |
| 6 | Ridgetech | 58,250.67 | -17.85 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 260,402.00 |
| Mar 31, 2026 | 460,402.00 |
| May 31, 2022 | 7,050.00 |
| Feb 28, 2022 | 7,050.00 |
| Nov 30, 2021 | 7,050.00 |
| Aug 31, 2021 | 7,050.00 |